Calendar Greenwich LifeSciences, Inc.

Equities

GLSI

US3968791083

Market Closed - Nasdaq 04:00:00 2024-04-22 pm EDT 5-day change 1st Jan Change
12.69 USD +5.14% Intraday chart for Greenwich LifeSciences, Inc. -11.01% +20.63%

Chart calendar Greenwich LifeSciences, Inc.

0cf4f9.BY_U_gP1A64KFJMRke7faTs8zMTDeg_-CDc2mUtaRd0.dMmVvXfCUJlnJdF68tebL0ptp520Dm2yRnJPrgIZM5s3_bKYSK9i_0N-4A~18356a9ad2eba8d8de767a44254e175c

Upcoming events on Greenwich LifeSciences, Inc.

No events available

Past events on Greenwich LifeSciences, Inc.

2023-12-15 09:00 am Annual General Meeting
2022-12-08 Annual General Meeting
2022-06-12 BIO International Convention
2022-06-07 Jefferies Healthcare Conference
2022-06-02 American Society of Clinical Oncology Meeting - Abstract Number: TPS1110
2022-06-02 American Society of Clinical Oncology Meeting - Abstract Number: e12519
2022-06-02 American Society of Clinical Oncology Meeting - Abstract Number: LBA550
2022-05-22 H.C. Wainwright Global Life Sciences Investment Conference
2022-04-07 American Association of Cancer Research Meeting
2022-03-27 BIO Europe Spring
2022-02-14 02:30 pm Bio CEO & Investor Conference
2021-12-15 09:00 am Annual General Meeting
2021-12-06 San Antonio Breast Cancer Symposium
2021-11-15 Jefferies London Healthcare Conference
2021-09-29 02:00 pm Cantor Fitzgerald Global Healthcare Conference
2021-09-29 09:30 am Benzinga Healthcare Small Cap Conference
2021-09-12 H.C. Wainwright Global Investment Conference
2021-09-07 Citigroup BioPharma Conference
2021-04-09 American Association for Cancer Research Conference
2021-03-24 Benzinga Biotech Small-Cap Conference

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
0,00


0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-

0,00

EBITDA
Released
Forecast
Spread
0,00


0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-

0,00

EBIT
Million USD
Released
Forecast
Spread
0,00


-1,86
-13,0
85.66%
-4,60
-3,17
-45%
-8,04
-7,50
-7.26%
-9,33
-9,04
-3.16%

-10,2

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
0,00


0,00
0,00
-
-4,57
-3,16
-44.64%
-7,83
-7,40
-5.69%
-8,89
-8,70
-2.26%

-10,2

Net income
Million USD
Released
Forecast
Spread
-3,43


-1,86
-13,0
85.67%
-4,57
-3,16
-44.64%
-7,83
-7,39
-5.96%
-8,89
-8,70
-2.26%

-10,2

EPS
USD
Released
Forecast
Spread
-1,52


-0,20
-1,02
80.39%
-0,35
-0,24
-45.83%
-0,61
-0,57
-7.02%
-0,69
-0,68
-1.47%

-0,76

Announcement Date29/05/2031/03/2121/03/2231/03/2315/04/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales
Million USD
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-

0,00


0,00


0,00


0,00

EBIT
Million USD
Released
Forecast
Spread
-2,38
-0,95
-150.23%
-1,99
-2,45
18.81%
-0,77
-2,45
68.44%
-2,38
-2,45
2.73%
-2,89
-2,35
-23.18%
-2,24
-3,00
25.3%
-1,75
-3,00
41.74%
-2,50
-3,00
16.57%
-2,84
-2,55
-11.22%












Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-2,36
-0,95
-148.5%
-1,97
-2,45
19.61%
-0,75
-2,45
69.55%
-2,32
-2,45
5.35%
-2,79
-2,35
-18.75%
-2,12
-3,00
29.17%
-1,63
-3,00
45.72%
-2,39
-3,00
20.27%
-2,75
-2,55
-7.72%












Net income
Million USD
Released
Forecast
Spread
-2,36
-0,95
-148.5%
-1,97
-2,45
19.61%
-0,75
-2,45
69.55%
-2,32
-2,45
5.35%
-2,79
-2,35
-18.75%
-2,12
-3,00
29.17%
-1,63
-3,00
45.72%
-2,39
-3,00
20.27%
-2,75
-2,55
-7.72%












EPS
USD
Released
Forecast
Spread
-0,18
-0,07
-157.14%
-0,15
-0,19
21.05%
-0,06
-0,19
68.42%
-0,18
-0,19
5.26%
-0,22
-0,18
-22.22%
-0,17
-0,23
26.09%
-0,13
-0,23
43.48%
-0,19
-0,22
13.64%
-0,21
-0,20
-5%

-0,20


-0,20


-0,19


-0,18

Announcement Date21/03/2220/05/2215/08/2214/11/2231/03/2322/05/2321/08/2319/10/2315/04/24----

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. GLSI Stock
  4. Calendar Greenwich LifeSciences, Inc.